
Exemestabe Tablets
| Product/Composition | Exemestane Tablets |
|---|---|
| Form | 25mg, Tablets |
| Production Capacity | 1,000,000 Tablets |
| Therapeutic use | breast cancer |
| Package Insert/Leaflet | Available upon request |
Exemestane Tablets are a medicine classified as an aromatase inhibitor, primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women.
Here are the key details:
-
Composition: Each tablet contains Exemestane as the active ingredient, commonly in a 25 mg strength.
-
Dosage Form: Oral tablets, usually taken once daily after a meal, as prescribed by a doctor.
-
Mode of Action:
-
Exemestane inhibits the aromatase enzyme, which is responsible for converting androgens into estrogen.
-
By lowering estrogen levels in the body, it reduces the growth stimulus for estrogen-dependent breast cancer cells.
-
-
Uses:
-
Hormone receptor-positive breast cancer – often used after surgery, radiation, or chemotherapy to prevent recurrence.
-
May be used in cases where other hormonal therapies (like tamoxifen) are no longer effective.
-
-
Treatment Goal: To reduce estrogen levels, slow cancer growth, and prevent recurrence in estrogen-sensitive breast cancers.
-
Side Effects:
-
Common: hot flashes, joint pain, fatigue, headache, nausea, increased sweating.
-
Less common/serious: bone thinning (osteoporosis), fractures, high cholesterol, liver function changes, mood changes.
-
-
Precautions:
-
Regular monitoring of bone density and cholesterol levels is recommended during long-term use.
-
Not recommended during pregnancy or breastfeeding.
-
Patients may need calcium and vitamin D supplementation to support bone health.
-
Should be taken exactly as prescribed, usually for several years depending on the treatment plan.
-
👉 Exemestane is effective in postmenopausal women with hormone-sensitive breast cancer because it specifically targets estrogen production, reducing the risk of cancer recurrence.